tirzepatide vision side effects Mounjaro Eye Lawsuit [2026 Update] Can Tirzepatide Cause Blindness? What

Semaglutide selectively activates the GLP-1 receptor, a pathway involved in regulating insulin secretion, glucagon release, gastric emptying and appetite signalling

The risk of using GLP-1 receptor agonists to treat IIH seems to lie primarily in the potential for individuals to rapidly regain the lost weight after cessation of treatment, as seen in the above case

Bass, Sometimes an extra dose or a different laxative is needed. Troubleshooting colonoscopy prep issues If not experiencing bowel movement ahead of a colonoscopy, any of the above issues could be at play

Most patients begin noticing some weight loss within the first few weeks of starting a GLP-1 agonist, especially as the dose is gradually increased to the optimal maintenance level

J Neurotrauma

Losing just 510% of body weight is often enough to significantly improve health markers (blood sugar, blood pressure, etc.), and Mounjaro enabled a very high proportion of patients to achieve this benchmark